The Örebro Severe Traumatic Brain Injury Registry

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAndrás Zoltán Buki

About this trial

Traumatic brain injury and other severe brain injuries requiring neurointensive care are associated with high mortality, long-term disability and substantial societal burden. Despite advances in critical care, outcomes after severe brain injury remain difficult to predict and secondary brain injury plays a major role in determining prognosis.

The Örebro Severe Brain Injury Database (ÖrSBID) is a prospective observational registry that aims to systematically collect detailed clinical, physiological, imaging and biological data from adult patients with severe brain injury requiring care at the neurointesive care unit or neurointermediate care unit at Örebro University Hospital.

The purpose of the registry is to enable deep phenotyping of severe brain injury, improve understanding of secondary injury mechanisms, support outcome prediction and provide a platform for longitudinal follow-up and future research. No experimental interventions are performed as part of the study.

Eligibility criteria

Qualifiers

Age > 16 years

Severe traumatic brain injury or other severe brain injury requiring neurointensive or neurointermediate care

Admission to Örebro University Hospital

Disqualifiers

Age < 16 years < 90 years

Non-survivable brain injury

Patients not requiring neurointensive or neurointermediate care

Declinced consent by patient or legal representative

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

200 Participants
are grouped into 1 trial group

Sponsors and collaborators

András Zoltán Buki

Lead sponsor

Region Orebro lan

Sponsor institution